4//SEC Filing
North Annette 4
Accession 0001209191-21-054117
CIK 0001595893other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 5:26 PM ET
Size
9.0 KB
Accession
0001209191-21-054117
Insider Transaction Report
Form 4
North Annette
EVP, General Counsel & Secty.
Transactions
- Exercise/Conversion
Common Stock
2021-08-30$17.00/sh+10,000$170,000→ 22,365 total - Sale
Common Stock
2021-08-30$80.00/sh−10,000$800,000→ 12,365 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-30−10,000→ 144,609 totalExercise: $17.00Exp: 2029-04-14→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
- [F2]One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001341011
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 5:26 PM ET
- Size
- 9.0 KB